

( (S (PP From
         (NP (NP a reading)
             (PP of
                 (NP (NP the
			 (ADJP somewhat scant)
			 English-language medical literature)
                     (PP on
                         (NP RU-486))))))
     ,
     (NP-SBJ the French abortion pill)
     (VP emerges
         (PP-CLR as
		 (NP (NP one)
		     (PP of
			 (NP (NP the creepiest concoctions)
			     (ADVP-LOC around))))))
     .))
( (S (NP-SBJ This)
     (VP is
         (ADVP not only)
         (SBAR-PRP-PRD because
		       (S (NP-SBJ it)
			  (VP (NP kills
				  (NP the unborn))
			      ,
			      (NP-ADV (NP a job)
				      (SBAR (WHPP-2 at
						    (WHNP which))
					    (S (NP-SBJ-3 it)
					       (ADVP actually)
					       (VP is not
						   (ADJP-PRD outstandingly efficient
							     (PP *T*-2))
						   ,
						   (S-ADV (NP-SBJ *-3)
							  (VP zapping
							      (NP (NP (QP only 50 % to 85 %) *U*)
								  (PP of
								      (NP them)))
							      (PP depending
								  (PP on
								      (SBAR-NOM (WHNP-1 which study)
										(S (NP-SBJ you)
										   (VP read
										       (NP *T*-1)))))))))
					       (PRN -LRB-
						    (S (NP-SBJ-4 prostaglandin)
						       ,
						       (S-ADV (NP-SBJ *-4)
							      (VP taken
								  (NP *)
								  (PP-CLR in
									  (NP (NP conjunction)
									      (PP with
										  (NP the pill))))))
						       ,
						       (VP boosts
							   (NP the rate)
							   (PP-CLR to
								   (NP 95 %))))
						    -RRB-))))))))
     .))
( (S (PP By
         (NP contrast))
     ,
     (NP-SBJ surgical abortion)
     (VP is
         (ADJP-PRD (NP-ADV 99 %)
		   effective))
     .))
( (S (NP-SBJ (NP Abortion)
             (PP via
                 (NP the pill)))
     (VP is
         (ADJP-PRD (ADJP far more
			 (PP of
			     (NP an ordeal)))
		   (PP than
		       (NP conventional surgical abortion))))
     .))
( (S (NP-SBJ It)
     (VP is
         (ADJP-PRD (ADJP time-consuming)
		   (PRN -LRB-
			(S (S (NP-SBJ (NP the abortion part)
				      (ADVP alone))
			      (VP lasts
				  (NP three days)))
			   , and
			   (S (NP-SBJ the clinical part)
			      (VP comprises
				  (NP (NP (NP a week 's)
					  worth)
				      (PP of
					  (NP visits))))))
			-RRB-)
		   ,
		   (ADJP bloody)
		   (PRN -LRB-
			(S (NP-SBJ (NP one woman)
				   (PP-LOC in
					   (NP a Swedish trial)))
			   (VP required
			       (NP a transfusion)
			       ,
			       (SBAR-ADV although
					 (S (PP for
						(NP most))
					    (NP-SBJ it)
					    (VP resembles
						(NP a menstrual period)
						,
						(PP with
						    (NP (NP bleeding)
							(VP lasting
							    (NP (NP an average)
								(PP of
								    (NP 10 days)))))))))))
			-RRB-)
		   , and
		   (ADJP painful)
		   (PRN -LRB-
			(S (NP-SBJ-1 many women)
			   (VP require
			       (NP analgesic shots)
			       (S-PRP-CLR (NP-SBJ *-1)
					  (VP to
					      (VP ease
						  (NP them)
						  (ADVP-CLR through))))))
			-RRB-)))
     .))
( (S (NP-SBJ Nausea
             and
             vomiting)
     (VP are
         (NP-PRD other common side effects))
     .))
( (S (NP-SBJ Timing)
     (VP is
         (PP-PRD of
		 (NP the essence))
         (PP with
             (NP RU-486)))
     .))
( (S (NP-SBJ-2 It)
     (VP is
         (ADJP-PRD most effective)
         (S-ADV (NP-SBJ-3 *-2)
		(VP taken
		    (NP *-3)
		    (UCP-TMP (SBAR (NP-ADV about a week)
				   after
				   (S (NP-SBJ a woman)
				      (VP misses
					  (NP her menstrual period))))
			     (PP up through 
				 (NP (NP the seventh week)
				     (PP of
					 (NP pregnancy))
				     ,
				     (SBAR-TMP (WHADVP-1 when)
					       (S (NP-SBJ it)
						  (VP is
						      (ADJP-PRD markedly less effective)
						      (ADVP-TMP *T*-1))))))))))
     .))
( (S (NP-SBJ That)
     (VP is
         (ADVP typically)
         (NP-PRD about a three-week window))
     .))
( (S (ADVP-TMP So far)
     ,
     (NP-SBJ all the studies)
     (VP have
         (VP concluded
             (SBAR that
                   (S (NP-SBJ RU-486)
                      (VP is ``
                          (ADJP-PRD safe))))))
     . ''))
( (S But
     ``
     (ADJP-SBJ safe)
     (PRN , ''
	  (PP in
	      (NP (NP the definition)
		  (PP of
		      (NP (NP Marie Bass)
			  (PP of
			      (NP the Reproductive Health Technologies Project))))))
	  ,)
     (VP means
	 (SBAR 0
	       ``
	       (S (NP-SBJ there)
		  (VP 's
		      (VP been
			  (NP-PRD (NP no evidence)
				  (PP *ICH*-1))
			  (ADVP-TMP so far)
			  (PP-1 of
				(NP mortality)))))))
     .
     ''))
( (S (NP-SBJ No one)
     (VP has
         (VP researched
             (NP (NP the long-term effects)
                 (PP of
                     (NP RU-486))
                 (PP on
                     (NP (NP a woman 's)
                         health or fertility)))))
     .))
( (S (NP-SBJ-2 The drug)
     (VP seems
         (S (NP-SBJ *-2)
            (VP to
                (VP suppress
                    (NP ovulation)
                    (PP-TMP for
			    (NP (NP (QP three to seven)
				    months)
				(SBAR-TMP after 
					  (S (NP-SBJ-1 it)
					     (VP is
						 (VP taken
						     (NP *-1)))))))))))
     .))
( (S (S (NP-SBJ Some women)
        (ADVP clearly)
        (VP have
	    (NP (NP no trouble)
		(S-NOM (NP-SBJ *)
		       (ADVP-TMP eventually)
		       (VP conceiving
			   (ADVP again))))))
     :
     (S (NP-SBJ The studies)
        (VP have
            (VP reported
                (NP repeaters)
                (PP-LOC in
			(NP their programs)))))
     .))
( (S But
     (NP-SBJ there)
     (VP are
         (NP-PRD (NP no scientific data)
		 (PP on
		     (NP this question))))
     .))
( (S (S-TPC-1 (ADVP Rather ominously)
	      ,
	      (NP-SBJ rabbit studies)
	      (VP reveal
		  (SBAR that
			(S (NP-SBJ RU-486)
			   (VP can
			       (VP cause
				   (NP birth defects)))))))
     ,
     (NP-SBJ (NP Lancet)
	     ,
	     (NP the British medical journal)
	     ,)
     (VP reported
	 (SBAR 0
	       (S *T*-1))
	 (PP-TMP in
		 (NP 1987)))
     .))
( (S (ADVP However)
     ,
     (NP-SBJ (NP Dr. Etienne-Emile Baulieu)
             ,
             (NP (NP the French physician)
                 (SBAR (WHNP-488 who)
                       (S (NP-SBJ *T*-488)
                          (VP invented
                              (NP RU-486)))))
             ,)
     (VP wrote
         (PP-LOC in
		 (NP a Science magazine article))
	 (NP-TMP last month)
         (SBAR that
               (S (NP-SBJ-487 the rabbit-test results)
                  (VP could not
                      (VP be
                          (VP duplicated
                              (NP *-487)
                              (PP in
				  (NP rats and monkeys))))))))
     .))
( (S (NP-SBJ The drug)
     (VP has
         (NP (NP a three-dimensional structure)
             (ADJP similar
                   (PP to
                       (NP (NP that)
                           (PP of
                               (NP (NP DES)
                                   ,
                                   (NP (NP the anti-miscarriage drug)
				       (SBAR (WHNP-3 that)
					     (S (NP-SBJ-1 *T*-3)
						(VP has
						    (VP been
							(VP linked
							    (NP *-1)
							    (PP-CLR to
								    (NP cervical and vaginal cancer))
							    (PP-LOC in
								    (NP (NP some)
									(PP of
									    (NP (NP the daughters)
										(PP of
										    (NP (NP the women)
											(SBAR (WHNP-2 who)
											      (S (NP-SBJ *T*-2)
												 (VP took
												     (NP it)))))))))))))))))))))))
     .))
( (S (NP-SBJ All the published studies)
     (VP recommend
         (SBAR that
               (S (NP-SBJ (NP women)
                          (SBAR (WHPP-1 on
					(WHNP whom))
                                (S (NP-SBJ the drug)
                                   (VP proves
                                       (ADJP-PRD ineffective)
				       (PP *T*-1)))))
                  (VP not
                      (VP carry
                          (NP the pregnancy)
			  (PP-CLR to
				  (NP term)))
                      but
                      (VP undergo
                          (NP a surgical abortion))))))
     .))
( (S (NP-SBJ (NP (NP A risk)
                 (PP of
                     (NP birth defects)))
             ,
             (NP (NP a sure source)
                 (PP of
                     (NP lawsuits)))
             ,)
     (VP is
         (NP-PRD (NP one reason)
		 (SBAR (WHADVP-1 0)
		       (S (NP-SBJ the U.S. pharmaceutical industry)
			  (VP is
			      (VP steering
				  (ADVP-CLR clear
					    (PP of
						(NP RU-486)))
				  (ADVP-PRP *T*-1)))))))
     .))
( (S (NP-SBJ One)
     (VP might
         (ADVP well)
         (VP ask
	     :
             (SBARQ (WHADVP-1 Why)
                    (SQ (NP-SBJ *) 
                        (VP bother
                            (PP with
                                (NP this drug))
                            (ADVP at all)
			    (ADVP-PRP *T*-1))))))
     ?))
( (S (NP-SBJ Some abortion advocates)
     (VP have
         (VP been
             (VP asking
                 (NP themselves)
                 (NP this very question))))
     .))
((SINV (S-TPC-2 (NP-SBJ RU-486)
		``
		(VP (ADVP probably)
		    represents
		    (NP (NP a technical advance)
			(PP-LOC in
				(NP (NP an area)
				    (SBAR (WHADVP-1 where)
					  (S (NP-SBJ-487 none)
					     (VP is
						 (VP needed
						     (NP *-487)
						     (PRN , or
							  (ADVP (ADVP at least)
								not very much))
						     (ADVP-LOC *T*-1))))))))))
       ,
       ''
       (VP said
	   (SBAR 0
		 (S *T*-2)))
       (NP-SBJ (NP Phillip Stubblefield)
	       ,
	       (NP (NP president)
		   (PP of
		       (NP the National Abortion Federation)))
	       ,)
       (PP-LOC at
	       (NP a reproductive health conference))
       (PP-TMP in
	       (NP 1986))
       .))
( (S (NP-SBJ Many physicians)
     (VP have
         (VP expressed
             (NP (NP concern)
                 (PP over
                     (NP (NP the heavy bleeding)
                         ,
                         (SBAR (WHNP-1 which)
                               (S (NP-SBJ *T*-1)
                                  (VP occurs
                                      (SBAR-ADV even if
						(S (NP-SBJ-2 the drug)
						   (VP fails
						       (S (NP-SBJ *-2)
							  (VP to
							      (VP induce
								  (NP an abortion)))))))))))))))
     .))
( (S (S (NP-SBJ (NP It)
		(S *EXP*-1))
        (ADVP typically)
        (VP takes
	    (NP (QP from eight to 10)
		years)
            (S-1 (NP-SBJ *)
		 (VP to
		     (VP obtain
			 (NP (NP the Food and Drug Administration 's)
			     approval)
			 (PP for
			     (NP a new drug)))))))
     , and
     (S (NP-SBJ (NP the cost)
                (PP of
                    (S-NOM (NP-SBJ *)
			   (VP testing
			       and
			       marketing
			       (NP a new drug)))))
        (VP can
            (VP range
                (PP-CLR (PP from
			    (NP (QP $ 30 million) *U*))
			(PP to
			    (NP (QP $ 70 million) *U*))))))
     .))
( (S (NP-SBJ The Health and Human Services Department)
     (ADVP-TMP currently)
     (VP forbids
         (NP-1 (NP the National Institutes)
	       (PP of
		   (NP Health)))
         (PP-CLR from
		 (S-NOM (NP-SBJ *-1)
			(VP funding
			    (NP abortion research)
			    (PP-MNR as
				    (NP (NP part)
					(PP of
					    (NP its (ADJP (QP $ 8 million) *U*) contraceptive program ))))))))
     .))
( (S But
     (NP-SBJ (NP the Population Council)
             ,
             (NP (NP a 37-year-old , (ADJP (QP $ 20 million) *U*) nonprofit organization )
                 (SBAR (WHNP-487 that)
                       (S (NP-SBJ *T*-487)
                          (VP (VP has
                                  (NP (NP the backing)
                                      (PP of
                                          (NP the Rockefeller and Mellon foundations))))
                              and
                              (VP (ADVP-TMP currently)
                                  subsidizes
                                  (NP (NP most U.S. research)
                                      (PP on
                                          (NP contraceptives))))))))
             ,)
     (VP has
         (ADVP-TMP recently)
         (VP been
             (VP paying
                 (PP-CLR for
			 (NP (NP U.S. studies)
			     (PP of
				 (NP RU-486))
			     (PP on
				 (NP (NP a license)
				     (PP from
					 (NP (NP its French developer)
					     ,
					     (NP (NP Roussel-Uclaf)
						 ,
						 (NP (NP a joint subsidiary)
						     (PP of
							 (NP (NP (NP the German pharmaceutical company Hoechst))
							     and
							     (NP the French government))))))))))))))
     .))
( (S (PP-TMP In
	     (NP (NP the year)
		 (SBAR-TMP since
			   (S (NP-SBJ the pill)
			      (VP went
				  (PP-CLR on
					  (NP the French market)))))))
     ,
     (NP-SBJ-1 (NP the National Organization for Women)
	       and
	       (NP (NP its offshoot)
		   ,
		   (NP (NP (NP former NOW President Eleanor Smeal 's)
			   Fund)
		       (PP for
			   (NP a Feminist Majority)))
		   ,))
     (VP have
         (VP been
             (VP trying
                 (S (NP-SBJ *-1)
                    (VP to
                        (VP browbeat
                            (NP-2 the U.S. pharmaceutical industry)
                            (PP-CLR into
				    (S-NOM (NP-SBJ *-2)
					   (VP getting
					       (ADJP-PRD involved))))))))))
     .))
( (FRAG -LRB-
	(NP Its scare-tactic prediction)
	:
	(S (NP-SBJ the pill)
	   ``
	   (VP will
	       (VP be
		   (ADJP-PRD available)
		   (PP-LOC in
			   (NP the U.S.))
		   ,
		   (ADVP either legally or illegally)
		   ,
		   (PP-TMP in
			   (NP (QP no more than 2-5) 
			       years)))))
	. '' -RRB-))
( (SINV (VP-TPC-1 Following
		  (NP the feminist and population-control lead))
        (VP has
	    (VP been
		(VP *T*-1)))
	(NP-SBJ a
                (ADJP generally bovine)
                press)
        .))
( (S (NP-SBJ (NP A June 1988 article)
             (PP-LOC in
		     (NP Mother Jones magazine)))
     (VP is
         (ADJP-PRD typical
		   (PP of
		       (NP (NP the general level)
			   (PP of
			       (NP media ignorance))))))
     .))
( (SINV ``
	(S-TPC-1 (PP For
		     (NP (NP a woman)
			 (SBAR (WHNP-487 whose period)
			       (S (NP-SBJ *T*-487)
				  (VP is
				      (ADJP-PRD late))))))
		 ,
		 (S-NOM-SBJ (NP-SBJ *)
			    (VP using
				(NP RU-486)))
		 (VP means
		     (NP (NP no waiting)
			 ,
			 (NP (NP no walking)
			     (PP past
				 (NP (NP picket lines)
				     (PP-LOC at
					     (NP abortion clinics)))))
			 , and
			 (NP (NP no feet)
			     (PP up
				 (PP in
				     (NP stirrups)))
			     (PP for
				 (NP surgery))))))
	,
	''
	(VP burbles
	    (S *T*-1))
	(NP-SBJ health writer Laura Fraser)
	.))
( (S ``
     (NP-SBJ It)
     (ADVP also)
     (VP means
         (SBAR 0
               (S (NP-SBJ-1 she)
                  (VP will
                      (ADVP-TMP never)
                      (VP have
                          (S (NP-SBJ *-1)
                             (VP to
                                 (VP know
                                     (SBAR whether
                                           (S (NP-SBJ she)
                                              (VP had
                                                  (ADVP actually)
                                                  (VP been
                                                      (ADJP-PRD pregnant)))))))))))))
     . ''))
( (FRAG (ADJP Wrong
	      (PP on
		  (NP all counts)))
	,
	(NP-VOC Miss Fraser)
	.))
( (S (NP-SBJ-487 RU-486)
     (VP is
         (VP being
             (VP administered
                 (NP *-487)
                 (PP-LOC in
			 (NP France))
                 (ADVP only)
                 (PP-LOC under
			 (NP strict supervision))
                 (PP in
		     (NP (NP the presence)
			 (PP of
			     (NP a doctor)))))))
     .))
( (S -LRB-
     (NP-SBJ Roussel)
     (ADVP reportedly)
     (VP has
         (S (NP-SBJ-1 every pill)
	    (VP (VP marked
		    (NP *-1))
		and
		(VP accounted
		    (PP-CLR for
			    (NP *-1)))
		(S-PRP (NP-SBJ *)
		       (VP to
			   (VP make
			       (ADJP sure
				     (SBAR 0
					   (S (NP-SBJ none)
					      (VP slips
						  (PP-DIR into
							  (NP the black market))))))))))))
     . -RRB-))
( (S (ADVP Thus)
     ,
     (NP-SBJ-1 (NP a woman)
	       (SBAR (WHNP-487 who)
		     (S (NP-SBJ-3 *T*-487)
			(VP used
			    (NP RU-486)
			    (S-CLR (NP-SBJ *-3)
				   (VP to
				       (VP have
					   (NP an abortion))))))))
     (VP would
         (VP have
             (S (NP-SBJ *-1)
                (VP to
                    (VP make
                        (NP (NP (NP three trips)
                                (PP to
                                    (NP the clinic))
                                (PP past
                                    (NP those picket lines)))
                            ;
                            (NP (NP (NP an initial visit)
                                    (UCP-PRP (PP for
						 (NP (NP medical screening)
						     (PRN -LRB-
							  (S (NP-SBJ-4 (NP anemics)
								       and
								       (NP (NP those)
									   (PP with
									       (NP previous pregnancy problems))))
							     (VP are
								 (VP eliminated
								     (NP *-4))))
							  -RRB-)))
					     and
					     (S (NP-SBJ *)
						(VP to
						    (VP take
							(NP the pill))))))
                                ,
                                (NP (NP a second trip)
                                    (ADVP-TMP (NP 48 hours)
					      later)
                                    (PP for
                                        (NP (NP the prostaglandin)
                                            ,
                                            (VP administered
                                                (NP *)
                                                (PP either via
                                                    (NP (NP injection)
                                                        or
                                                        (NP vaginal suppository)))))))
                                , and
                                (NP (NP a third trip)
                                    (ADVP-TMP (NP a week)
					      later)
                                    (S-PRP (NP-SBJ *)
					   (VP to
					       (VP make
						   (ADJP sure
							 (SBAR 0
							       (S (NP-SBJ she)
								  (VP has
								      (VP (ADVP completely)
									  aborted))))))))))))))))
     .))
( (S (ADVP Furthermore)
     ,
     (SBAR-PRP because
	       (S (NP-SBJ timing)
		  (VP is
		      (ADJP-PRD so critical)
		      (PP with
			  (NP RU-486)))))
     ,
     (NP-SBJ she)
     (VP will
	 (VP learn
	     ,
	     (PP via
		 (NP a pelvic examination and ultrasound))
	     ,
	     (SBAR (ADVP not only)
		   (SBAR that
			 (S (NP-SBJ she)
			    (VP is
				(ADJP-PRD pregnant))))
		   , but
		   (SBAR (WHADJP-1 just how pregnant)
			 (S (NP-SBJ she)
			    (VP is
				(ADJP-PRD *T*-1)))))))
     .))
( (S (NP-SBJ (NP No doctor)
             (SBAR (WHNP-1 who)
                   (S (NP-SBJ *T*-1)
                      (VP fears
                          (NP malpractice liability)))))
     (VP would
         (VP (ADVP likely)
             expose
             (NP a non-pregnant patient)
             (PP-CLR to
		     (NP (NP the risk)
			 (PP of
			     (NP hemorrhaging))))))
     .))
( (S (NP-SBJ Many women)
     (VP may
         (VP (ADVP even)
             see
             (NP (NP (NP the dead embryo)
                     (SBAR (WHNP-1 0)
                           (S (NP-SBJ they)
                              (VP have
                                  (VP expelled
				      (NP *T*-1))))))
                 ,
                 (NP (NP a sight)
                     (SBAR (WHNP-2 0)
                           (S (NP-SBJ the surgical-abortion industry)
                              (ADVP typically)
                              (VP spares
                                  (NP them)
				  (NP *T*-2))))))))
     .))
( (S (PP-TMP At
	     (NP seven weeks))
     ,
     (NP-SBJ an embryo)
     (VP is
         (ADJP-PRD (ADJP (NP-ADV (NP (QP about three-fourths))
				 (PP of
				     (NP an inch)))
			 long)
		   and
		   (ADJP recognizably human)))
     .))
( (S (PP At
         (NP (NP the behest)
             (PP of
                 (NP (NP pro-choice members)
                     (PP of
                         (NP Congress))))))
     ,
     (NP-SBJ (NP a four-year reauthorization bill)
             (PP for
                 (NP Title X federal family-planning assistance)))
     (ADVP-TMP now)
     (VP contains
         (NP (NP a (ADJP (QP $ 10 million) *U*) grant)
             (PP for
                 (NP ``
                     (NP (NP development)
                         ,
                         (NP evaluation)
                         and
                         (NP (NP bringing)
                             (PP to
                                 (NP the marketplace))))
                     (PP of
                         (NP new improved contraceptive devices , drugs and methods))))))
     .
     ''))
( (S (SBAR-ADV If
	       (S (NP-SBJ this)
		  (VP passes)))
     (PRN --
	  (S (NP-SBJ-1 a Senate version)
	     (VP has
		 (ADVP-TMP already)
		 (VP been
		     (VP cleared
			 (NP *-1)
			 (PP-CLR for
				 (NP (NP a floor vote)
				     (SBAR (WHNP-2 that)
					   (S (NP-SBJ *T*-2)
					      (VP is
						  (ADJP-PRD likely)
						  (NP-TMP early next year))))))))))
	  --)
     (NP-SBJ it)
     (VP would
         (VP put
             (NP the federal government)
             (PP-PUT into
		     (NP the contraceptive marketing business))
             (PP-TMP for
		     (NP the first time))))
     .))
( (S (NP-SBJ It)
     (ADVP also)
     (VP could
	 (VP (VP put
		 (NP the government)
		 (PP-PUT into
			 (NP the RU-486 business)))
	     ,
	     (SBAR-ADV (WHNP-487 which)
		       (S (NP-SBJ *T*-487)
			  (VP would
			      (VP please
				  (NP (NP feminists)
				      (VP dismayed
					  (NP *)
					  (PP-CLR at
						  (SBAR-NOM (WHNP-488 what)
							    (S (NP-SBJ they)
							       (VP view
								   (NP *T*-488)
								   (PP-CLR as
									   (NP (NP pusillanimity)
									       (PP in
										   (NP the private-sector drug industry))))))))))))))))
     .))
( (S (NP-SBJ We)
     (VP do not
         (VP know
             (SBAR whether
                   (S (NP-SBJ RU-486)
                      (VP will
                          (VP be
                              (ADJP-PRD (ADJP as disastrous)
					(PP as
					    (NP (NP some)
						(PP of
						    (NP (NP the earlier fertility-control methods)
							(VP released
							    (NP *)
							    (PP-CLR to
								    (NP (NP unblinking , uncritical cheers)
									(PP from
									    (NP (NP educated people)
										(SBAR (WHNP-487 who)
										      (S (NP-SBJ *T*-487)
											 (VP should
											     (VP have
												 (VP known 
												     (ADVP better))))))))))))))))))))))
     .))
( (S -LRB- 
     (NP-SBJ *)
     (VP Remember
	 (NP (NP the Dalkon Shield)
	     and
	     (NP the early birth-control pills)))
     ? -RRB-))
( (S (NP-SBJ We)
     (VP will not
         (VP know
             (SBAR-TMP until
		       (S (NP-SBJ (NP a first generation)
				  (PP of
				      (NP (NP female guinea pigs)
					  (PRN --
					       (SBAR (WHNP-1 (WHNP all)
							     (WHPP of
								   (WHNP whom)))
						     (S (NP-SBJ-2 *T*-1)
							(VP will
							    (VP be
								(ADJP-PRD (ADVP more than) 
									  happy
									  (S (NP-SBJ *-2)
									     (VP to
										 (VP volunteer
										     (PP-CLR for
											     (NP the job))))))))))
					       --))))
			  (VP has
			      (VP put
				  (NP the abortion pill)
				  (PP-PUT through
					  (NP (NP the clinical test)
					      (PP of
						  (NP time))))))))))
     .))
( (S (NP-SBJ Mrs. Allen)
     (VP is
         (NP-PRD (NP a senior editor)
		 (PP of
		     (NP Insight magazine))))
     .))
( (S (NP-SBJ-1 This article)
     (VP is
         (VP adapted
             (NP *-1)
             (PP-CLR from
		     (NP (NP one)
			 (PP-LOC in
				 (NP the October American Spectator))))))
     .))
